Skip to main content
P

PathAI

PathAI develops AI-powered pathology technology that enhances diagnostic accuracy by providing pathologists with advanced image management and case management tools. The platform improves patient outcomes by streamlining laboratory workflows and facilitating biomarker discovery for drug development.

Boston, United StatesFounded 201627750K+ followers
Updated 4 months ago

Funding

$395.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional pathology workflows often rely on manual processes and subjective interpretation, leading to variability in diagnoses and hindering the efficient development of targeted therapies. The lack of standardized image management and analysis tools limits the ability to extract comprehensive insights from pathology data.

Solution

PathAI offers an AI-powered digital pathology platform, AISight, designed to enhance diagnostic accuracy and streamline laboratory workflows. The cloud-native system provides a centralized hub for case and image management, integrating AI-driven tools to support various histopathology use cases. By leveraging machine learning and a vast network of pathologist annotations, PathAI's technology aims to improve patient outcomes through more reliable diagnoses and accelerated biomarker discovery. The platform facilitates collaboration between pathologists and biopharmaceutical companies, enabling the development of precision medicine approaches.

Target Audience

PathAI's primary customers include pathology laboratories, research centers, and biopharmaceutical companies seeking to improve diagnostic accuracy, streamline workflows, and accelerate drug development.

Features

  • Cloud-native image management system for digital pathology workflows
  • AI-powered tools for image analysis and diagnostic support
  • Centralized hub for case management and collaboration
  • Proprietary network of 450+ board-certified pathologists contributing annotations
  • Algorithms trained and validated with over 15 million annotations
  • Integration with laboratory information systems (LIS)
This profile is AI-generated and may contain inaccuracies.